anaphylaxis

Scientists have developed an experimental vaccine that protects mice from life-threatening allergic reactions for at least a year. The vaccine, named IgE-K, targets immunoglobulin E antibodies to prevent anaphylaxis. Researchers hope it could offer long-term protection for humans with severe allergies.